Live Breaking News & Updates on Opaleye Management Inc

Stay updated with breaking news from Opaleye management inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Applied Therapeutics, Inc. (NASDAQ:APLT) Major Shareholder Sells $631,500.00 in Stock

Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) major shareholder Real Estate Equitie Alexandria sold 150,000 shares of Applied Therapeutics stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $4.21, for a total value of $631,500.00. Following the completion of the transaction, the insider now directly owns […] ....

Canada , United-states , Leerink-partnrs , Artal-group , Citigroup , Knoll-capital-management , Nasdaq , Opaleye-management-inc , Altitude-crest-partners-inc , Therapeutics-inc , Janus-henderson-group , Royal-bank

Short Interest in Allakos Inc. (NASDAQ:ALLK) Declines By 9.1%

Allakos Inc. (NASDAQ:ALLK – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 5,080,000 shares, a drop of 9.1% from the April 30th total of 5,590,000 shares. Based on an average daily volume of 528,900 shares, the days-to-cover ratio is […] ....

United-states , Allakos-inc , Redmile-group , Acadian-asset-management , Blackstone-inc , Opaleye-management-inc , Nasdaq , Get-free-report , Asset-management , Allakos-daily ,

Harrow, Inc. (NASDAQ:HROW) Short Interest Down 9.5% in May

Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 4,980,000 shares, a decline of 9.5% from the April 30th total of 5,500,000 shares. Based on an average daily volume of 510,400 shares, the […] ....

Markl-baum , Craig-hallum , Pricet-rowe-associates-inc , Surface-ophthalmics-inc , Pharmaceuticals-inc , Nasdaq , Opaleye-management-inc , Harrow-inc , Vanguard-group-inc , Harrow-health-inc , Eton-pharmaceuticals-inc , Get-free-report

iBio (NYSE:IBIO) Earns Buy Rating from Analysts at Chardan Capital

Chardan Capital assumed coverage on shares of iBio (NYSE:IBIO – Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $5.00 price target on the stock. Separately, StockNews.com started coverage on iBio in a research note on Saturday, April 20th. They issued a sell rating for the […] ....

United-states , Bio-inc , Ikarian-capital , Opaleye-management-inc , Chardan-capital , Free-report , Bio-trading-down , Get-free-report , Opaleye-management , Bio-daily ,

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Insider Sells $15,992.75 in Stock

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) insider Masaru Matsuda sold 1,775 shares of Arcutis Biotherapeutics stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $9.01, for a total transaction of $15,992.75. Following the transaction, the insider now directly owns 188,508 shares in the […] ....

Masaru-matsuda , Arcutis-biotherapeutics , Franklin-resources-inc , Nasdaq , Goldman-sachs-group , Farallon-capital-management , Arcutis-biotherapeutics-inc , Jennison-associates , Opaleye-management-inc , Securities-exchange-commission , Arcutis-biotherapeutics-company-profile , Needham-company